dc.contributor.author |
Taher A. |
dc.contributor.author |
Musallam K.M. |
dc.contributor.author |
El Rassi F. |
dc.contributor.author |
Duca L. |
dc.contributor.author |
Inati A. |
dc.contributor.author |
Koussa S. |
dc.contributor.author |
Cappellini M.D. |
dc.contributor.editor |
|
dc.date |
Sep-2009 |
dc.date.accessioned |
2017-10-05T15:37:39Z |
dc.date.available |
2017-10-05T15:37:39Z |
dc.date.issued |
2009 |
dc.identifier |
10.1111/j.1365-2141.2009.07810.x |
dc.identifier.isbn |
|
dc.identifier.issn |
00071048 |
dc.identifier.uri |
http://hdl.handle.net/10938/15862 |
dc.description.abstract |
Non-transferrin-bound iron (NTBI) was evaluated as an index of iron overload in a cross-sectional randomised study in 74 non-transfused patients with thalassaemia intermedia (TI). Mean NTBI (2.92 ± 3.43 μmol-l), serum ferritin (1023 ± 780 ng-ml) and liver iron concentration (LIC; 9.0 ± 7.4 mg Fe-g dry weight) were increased above reference-range levels. Significant positive correlations occurred between mean NTBI and LIC (Pearson correlation 0.36; P = 0.002) and serum ferritin (Pearson correlation 0.421; P 0.0001); with higher levels observed in splenectomised patients. NTBI assessment has potential as a simple reliable approach to determining iron status in TI. © 2009 Blackwell Publishing Ltd. |
dc.format.extent |
|
dc.format.extent |
Pages: (569-572) |
dc.language |
English |
dc.publisher |
MALDEN |
dc.relation.ispartof |
Publication Name: British Journal of Haematology; Publication Year: 2009; Volume: 146; no. 5; Pages: (569-572); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia |
dc.type |
Article |
dc.contributor.affiliation |
Taher, A., Department of Internal Medicine, Haematology-Oncology Division, American University of Beirut Medical Centre, Beirut 1107 2020, Lebanon, American University of Beirut, Beirut, Lebanon, Chronic Cancer Care Centre, Hazmieh, Lebanon |
dc.contributor.affiliation |
Musallam, K.M., American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
El Rassi, F., American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Duca, L., Universitá di Milano, Policlinico Foundation IRCCS, Milan, Italy |
dc.contributor.affiliation |
Inati, A., Chronic Cancer Care Centre, Hazmieh, Lebanon, Rafik Hariri University Hospital, Beirut, Lebanon |
dc.contributor.affiliation |
Koussa, S., Chronic Cancer Care Centre, Hazmieh, Lebanon |
dc.contributor.affiliation |
Cappellini, M.D., Universitá di Milano, Policlinico Foundation IRCCS, Milan, Italy |
dc.contributor.authorAddress |
Taher, A.; Department of Internal Medicine, Haematology-Oncology Division, American University of Beirut Medical Centre, Beirut 1107 2020, Lebanon; email: ataher@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine; |
dc.contributor.authorDepartment |
Internal Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
ataher@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Taher, A |
dc.contributor.authorInitials |
Musallam, KM |
dc.contributor.authorInitials |
El Rassi, F |
dc.contributor.authorInitials |
Duca, L |
dc.contributor.authorInitials |
Inati, A |
dc.contributor.authorInitials |
Koussa, S |
dc.contributor.authorInitials |
Cappellini, MD |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Taher, A (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, Haematol Oncol Div, Beirut 11072020, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
ALREFAIE FN, 1992, BRIT J HAEMATOL, V82, P431, DOI 10.1111-j.1365-2141.1992.tb06441.x; ARUOMA OI, 1988, BLOOD, V72, P1416; Cabantchik ZI, 2005, BEST PRACT RES CL HA, V18, P277, DOI 10.1016-j.beha.2004.10.003; Cappellini Maria Domenica, 2000, Transfusion Science, V23, P245; Chirnomas SD, 2008, AM J HEMATOL, V83, P781, DOI 10.1002-ajh.21221; Cighetti G, 2002, EUR J CLIN INVEST, V32, P55, DOI 10.1046-j.1365-2362.2002.0320s1055.x; FIORELLI G, 1990, HAEMATOLOGICA, V75, P89; Gosriwatana I, 1999, ANAL BIOCHEM, V273, P212, DOI 10.1006-abio.1999.4216; Origa R, 2007, HAEMATOL-HEMATOL J, V92, P583, DOI 10.3324-haematol.10842; Pakbaz Z, 2007, PEDIATR BLOOD CANCER, V49, P329, DOI 10.1002-pbc.21275; Piga A, 2009, AM J HEMATOL, V84, P29, DOI 10.1002-ajh.21317; Porter JB, 1996, BLOOD, V88, P705; St Pierre TG, 2005, ANN NY ACAD SCI, V1054, P379, DOI 10.1196-annals.1345.046; Taher A, 2008, HAEMATOL-HEMATOL J, V93, P1584, DOI 10.3324-haematol.13098; Tavazzi D, 2001, BRIT J HAEMATOL, V112, P48, DOI 10.1046-j.1365-2141.2001.02482.x |
dc.description.citedCount |
31 |
dc.description.citedTotWOSCount |
33 |
dc.description.citedWOSCount |
32 |
dc.format.extentCount |
4 |
dc.identifier.articleNo |
|
dc.identifier.coden |
BJHEA |
dc.identifier.pubmedID |
19604239 |
dc.identifier.scopusID |
68949212139 |
dc.identifier.url |
|
dc.publisher.address |
COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Br. J. Haematol. |
dc.relation.ispartOfIssue |
5 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
British Journal of Haematology |
dc.relation.ispartofPubTitleAbbr |
Br. J. Haematol. |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
146 |
dc.source.ID |
WOS:000268923700011 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
Iron overload |
dc.subject.otherAuthKeyword |
Non-transferrin-bound iron |
dc.subject.otherAuthKeyword |
Thalassaemia intermedia |
dc.subject.otherChemCAS |
ferritin, 9007-73-2 |
dc.subject.otherChemCAS |
transferrin, 82030-93-1 |
dc.subject.otherChemCAS |
Biological Markers |
dc.subject.otherChemCAS |
Ferritins, 9007-73-2 |
dc.subject.otherChemCAS |
Iron, 7439-89-6 |
dc.subject.otherIndex |
ferritin |
dc.subject.otherIndex |
iron binding protein |
dc.subject.otherIndex |
non transferrin bound iron |
dc.subject.otherIndex |
transferrin |
dc.subject.otherIndex |
unclassified drug |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
child |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
ferritin blood level |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
iron overload |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
priority journal |
dc.subject.otherIndex |
reference value |
dc.subject.otherIndex |
school child |
dc.subject.otherIndex |
splenectomy |
dc.subject.otherIndex |
thalassemia |
dc.subject.otherIndex |
thalassemia intermedia |
dc.subject.otherIndex |
Adolescent |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Biological Markers |
dc.subject.otherIndex |
Child |
dc.subject.otherIndex |
Cross-Sectional Studies |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Ferritins |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Iron |
dc.subject.otherIndex |
Iron Overload |
dc.subject.otherIndex |
Liver |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Middle Aged |
dc.subject.otherIndex |
Multivariate Analysis |
dc.subject.otherIndex |
Splenectomy |
dc.subject.otherIndex |
Thalassemia |
dc.subject.otherIndex |
Young Adult |
dc.subject.otherKeywordPlus |
BETA-THALASSEMIA |
dc.subject.otherKeywordPlus |
SERUM FERRITIN |
dc.subject.otherKeywordPlus |
PLASMA IRON |
dc.subject.otherKeywordPlus |
LIVER |
dc.subject.otherKeywordPlus |
THERAPY |
dc.subject.otherWOS |
Hematology |